Jim Simons's position in Rocket Pharmaceuticals is currently worth $1.53 Million. That's 0.00% of their equity portfolio (1995th largest holding). The first Rocket Pharmaceuticals trade was made in Q1 2018. Since then Jim Simons bought shares twelve more times and sold shares on thirteen occasions. The investor's estimated purchase price is $3.27 Million, resulting in a loss of 53%.